Dr. Reddy's launches immuno-oncology drug Toripalimab in India for nasopharyngeal carcinoma, expanding access to innovative treatment.

The museum is refocusing on Indy 500–related cars, so Michael Schumacher's rookie F1 car and the 1965 Le Mans–winning Ferrari ...

Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India.

KUALA LUMPUR: A 36-year-old man was threatened with death by a human trafficking syndicate if his family failed to pay a ...

Dr. Reddys has launched Toripalimab, a novel immuno-oncology drug, in India for treating recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). Toripalimab, already approved by USFDA and EMA, will ...

Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. This drug is designed to treat adults suffering ...

Right People, Wrong Place," opened at CGV Yongsan in central Seoul ahead of the film's global release on Dec. 5.

Auction house RM Sotheby's is sending under the hammer one of the eight Ford GT40 Mk II that competed in the 1966 Le Mans ...

The drug is the only immuno-oncology drug approved by various regulatory authorities around the world for the treatment of ...

Dr Reddy's launches toripalimab in India for the treatment of nasopharyngeal carcinoma: Our Bureau, Bengaluru Thursday, November 28, 2024, 12:15 Hrs [IST] Dr Reddy’s Laboratorie ...

Dr. Reddy’s Laboratories on Thursday announced the launch of Toripalimab in India to treat adults with Nasopharyngeal carcinoma (NPC) -- a rare and aggressive form of head and neck cancer that ...

New Delhi, Nov 28 (PTI) Dr Reddy's Laboratories on Thursday said it has launched Toripalimab, a drug for the treatment of recurrent or metastatic nasopharyngeal carcinoma in India. Nasopharyngeal ...